130 related articles for article (PubMed ID: 37129444)
21. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
22. Molecular and Computational Analysis Identify Statins as Selective Inhibitors of Human Butyrylcholinesterase.
Atay MS; Sari S; Bodur E
Protein J; 2023 Apr; 42(2):104-111. PubMed ID: 36648628
[TBL] [Abstract][Full Text] [Related]
23. Chicken retinospheroids as developmental and pharmacological in vitro models: acetylcholinesterase is regulated by its own and by butyrylcholinesterase activity.
Layer PG; Weikert T; Willbold E
Cell Tissue Res; 1992 Jun; 268(3):409-18. PubMed ID: 1628298
[TBL] [Abstract][Full Text] [Related]
24. Butyrylcholinesterase expression is regulated by fatty acids in HepG2 cells.
Gok M; Zeybek ND; Bodur E
Chem Biol Interact; 2016 Nov; 259(Pt B):276-281. PubMed ID: 27106529
[TBL] [Abstract][Full Text] [Related]
25. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP
Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671
[TBL] [Abstract][Full Text] [Related]
26. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
[TBL] [Abstract][Full Text] [Related]
27. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
[TBL] [Abstract][Full Text] [Related]
28. Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions.
Minic J; Chatonnet A; Krejci E; Molgó J
Br J Pharmacol; 2003 Jan; 138(1):177-87. PubMed ID: 12522088
[TBL] [Abstract][Full Text] [Related]
29. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Acetylcholinesterase and Butyrylcholinesterase by a Plant Secondary Metabolite Boldine.
Kostelnik A; Pohanka M
Biomed Res Int; 2018; 2018():9634349. PubMed ID: 29850593
[TBL] [Abstract][Full Text] [Related]
31. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of Fmoc-amino esters and amides bearing a substrate like quaternary ammonium group as selective butyrylcholinesterase inhibitors.
Godinez J; Lee CY; Schwans JP
Bioorg Med Chem Lett; 2023 Aug; 92():129392. PubMed ID: 37364726
[TBL] [Abstract][Full Text] [Related]
33. Evaluating Fmoc-amino acids as selective inhibitors of butyrylcholinesterase.
Gonzalez J; Ramirez J; Schwans JP
Amino Acids; 2016 Dec; 48(12):2755-2763. PubMed ID: 27522651
[TBL] [Abstract][Full Text] [Related]
34. A new series of pyridazinone derivatives as cholinesterases inhibitors: Synthesis, in vitro activity and molecular modeling studies.
Özçelik AB; Özdemir Z; Sari S; Utku S; Uysal M
Pharmacol Rep; 2019 Dec; 71(6):1253-1263. PubMed ID: 31675671
[TBL] [Abstract][Full Text] [Related]
35. Long-Chain Acylcholines Link Butyrylcholinesterase to Regulation of Non-neuronal Cholinergic Signaling.
Kinchen JM; Mohney RP; Pappan KL
J Proteome Res; 2022 Mar; 21(3):599-611. PubMed ID: 34758617
[TBL] [Abstract][Full Text] [Related]
36. Butyrylcholinesterase and lipid metabolism: Possible dual role in metabolic disorders.
Furtado-Alle L; Tureck LV; de Oliveira CS; Hortega JVM; Souza RLR
Chem Biol Interact; 2023 Sep; 383():110680. PubMed ID: 37634560
[TBL] [Abstract][Full Text] [Related]
37. Pure human butyrylcholinesterase hydrolyzes octanoyl ghrelin to desacyl ghrelin.
Schopfer LM; Lockridge O; Brimijoin S
Gen Comp Endocrinol; 2015 Dec; 224():61-8. PubMed ID: 26073531
[TBL] [Abstract][Full Text] [Related]
38. Piperazine derivatives with potent drug moiety as efficient acetylcholinesterase, butyrylcholinesterase, and glutathione S-transferase inhibitors.
Karaytuğ MO; Balcı N; Türkan F; Gürbüz M; Demirkol ME; Namlı Z; Tamam L; Gülçin İ
J Biochem Mol Toxicol; 2023 Feb; 37(2):e23259. PubMed ID: 36419212
[TBL] [Abstract][Full Text] [Related]
39. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
